Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

To help you effectively understand and manage the finances of your small business, we've tested the top accounting software based on customization, features, ease of use, value, and more. I’ve been ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

A better way to drive growth and profitability by Scott Magids, Alan Zorfas and Daniel Leemon When companies connect with customers’ emotions, the payoff can be huge. Consider these examples: After a ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Looking for ways to make some extra money this year? We've compiled a list of different passive income ideas to spark inspiration, including investing, real estate and a few niche options, like ...

Selecting the right web host is essential for online success. The best web hosting services we've tested cater to a wide range of users, from small bloggers to big businesses, and everything in ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Thomas J. Brock is a CFA and CPA with more ...

Exchange-traded funds can help you invest in multiple marijuana stocks. In 2014, Colorado and Washington became the first states to allow the sale of cannabis products. Since then, most states have ...